To me now is collection mode.. Bought 4.71

let the weak holder sell first. I believe afternoon will comeback even stronger.

AngTayKor......noted with thanks

https://www.thestar.com.my/business/business-news/2024/07/19/genting-plantations-to-acquire-152-hectares-in-indonesia-for-rm593mil-for-property-development

Genting Plantations to acquire 152 hectares in Indonesia for RM593mil for property development

RM5 coming soon.

Once UK approved. Commonwealth country can start selling. China and India may follow.

Waiting for more good news.

OTB - US cannot get. But UK possible.

TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer’s disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages of dementia due to Alzheimer’s disease.

HMTM has been designated by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the Innovative Licensing and Access Pathway (ILAP). If successful, the UK could be the first country in which an accessible, safe, oral treatment, which targets the hallmark tau pathology of the disease, becomes available to patients.

looking good. Keep it up.

The future is very bright.
Just hold on to your shares.

Well. Different person different opinions. Tomorrow will know. Game not over yet. TauRX results could be earlier.

I hope this round could break RM5 before TauRX year end approval.

https://www.thestar.com.my/business/business-news/2024/07/16/gentings-earnings-recovery-a-win

“We understand that TauRx ought to receive a reply by year end.

“Based on our estimates, if HMTM is approved and TauRx is valued at US$15bil, our SOP-based target price (TP) for Genting could be raised to RM9.35,” it noted.

In light of more favourable conditions, Maybank IB Research said it will maintain its “buy” call on Genting with a RM5.84 TP.

If TauRX really could approved this year, we should keep or buy more. TP RM6.50 should not be a problem.

You still has the chance to buy low as same thing will happen again and again.

Maybank is the biggest seller and not buyer. Same style same announcement everytime when someone has push the price to lowest and accumulate at lowest price then asking Maybank to announce good news and sell at highest price. So many times.

https://theedgemalaysia.com/node/718932

KUALA LUMPUR (July 15): Maybank Investment Bank (IB) said it's the “last calls for bets” in a note on Monday for Genting Bhd (KL:GENTING), whose sum-of-parts (SOP)-based target price (TP) may be raised to RM9.35, if its 20%-owned TauRx Pharmaceuticals ends up getting valued at US$15 billion (RM70.11 billion).

The research house maintained its 'buy' rating for Genting, with an unchanged TP of RM5.84, despite the group's 'lacklustre' share price. At the time of writing on Monday, Genting shares had fallen two sen or 0.4% to RM4.56, valuing the group at RM17.7 billion.

Despite Maybank IB’s longrunning optimism, investors remained cautious on the prospects of TauRx especially after US Food and Drug Administration (FDA) in March delayed its decision on Eli Lilly’s Alzheimer’s drug experimental treatment for early Alzheimer's disease. The delay by the FDA was the second after the regulator declined to grant accelerated approval for the medicine a year ago.
Requests for "Fast Track" designation are made by drug companies, and the US FDA will review and decide on the request "based on whether the drug fills an unmet medical need in a serious condition", according to the regulator's website.

Genting's share price has eased 2% year-to-date, while the FBM KLCI has appreciated 11%.

Maybank believes this is unfounded, considering that Genting’s earnings have been recovering well to near pre-Covid levels, driven by the return of visitors to both 49%-owned Resorts World Genting and 53%-owned Resorts World Sentosa.

The house said Genting's share price weakness was the result of foreign selling, due to a weaker ringgit against the US dollar. It opined that the foreign selling is likely to taper.

“We notice that there is a strong correlation between Genting's discount to SOP/share and the MYR/USD.
“Our foreign exchange research team forecasts the USD/MYR to recover to 4.600 by end-2024, and 4.500 by mid-2025, from 4.718 as at June 30.

“We expect this to narrow Genting's valuation discount to SOP/share to 60% (as per the level in the financial year ended Dec 31, 2022), from 65% currently,” the house added.

On July 1, TauRx announced its submission of the UK marketing authorisation application for an experimental drug, hydromethylthionine mesylate (HMTM), for the treatment of mild cognitive impairment and mild to moderate stages of Alzheimer’s.

If HMTM is approved by year end, the research house expects the pharmaceutical company to be valued up to US$15 billion, achieving Maybank’s forecast TP for Genting.

Testing water. If still warm will go up after lunch.

Monday open above 4.60 and slowly all the way up to 4.70.

Nobody know Q2 2924 result.
If good can go back to 4.80.
If got good news 5.00

3 hours ago I already told you all it's time to buy.

I got a feeling they are testing the shorties before the next move.
Just hold back as the price already very low. Once they have collect enough. They will push the the price up and sell. They have been playing the same way many round.

it's time to buy.
Don't ask why. just feeling.

Can see light in the tunnel.

When shortists short enough and collect enough at lower price.
Shortists will push the price up again to 4.80 before Q2 2024 result announcement.

We need to teach the shorter a lesson.

Could it be Shorter selling down or some other reasons ?
Can we act together killing the shorter by buying up ?

Michaelchan2024.......what is you average purchase price ? still holding.

NTA RM8.98
PE 12.72
Dividend 3.22%
Why keep selling down when company is making more profit and increase in revenue ?
Are you all selling at a loss or profit ?

Let us pray and hope for the best.

Since already got some projects announcement. So just wait until it's finalize.
Hopefully some project could achieve before year end.

Stampid54.....sure boh ?

that Thestar.com news is for ELI Lilly.

https://www.thestar.com.my/news/world/2024/07/03/new-alzheimer039s-treatment-approved-by-us-fda

New Alzheimer's treatment approved by U.S. FDA

Very disappointed.
Imaging if UK could approve TauRX this year, share price shouldn't have problem breaking RM5.
Why still got so many sellers ?

why so many people willing to sell at this time ?
Are they making profit or selling at a loss ?

I hope tomorrow will go up with this latest news on TauRX.

When US LA casino IPO listing could happen? This year?

Why so many people selling down ?

Once US listing approved, breaking RM5 should not be a problem.

Forget about the fire. Problem solved. Small issues.
waiting for US IPO and TauRX. Positive outlook.

TauRX still no estimate time frame ?

A lot of people still have no confidence in EV car in Malaysia. Charging may be a big issues. Peruduo also coming up with local EV car which is a lot cheaper. It will take a least 3 years to get people confident

Did AGM update about TauRX status?

RWLV to be listed? really? When? Can reduce bank loans.
l

If LGT still around he will be ashamed of LKT. Useless CEO useless son.

When is Genting Singapore AGM ?

Ask TauRX status, when can get approval?

Pinky,t
Just now 15.27pm big volume throwing down at at 4.69 and 4.68.
Then 15.33 pm another big buyer accumulating at 4.69 and 4.70.
Buyer can wait slowly accumulate but seller cannot pick up forcing to sell down.
So far 4.70 very good support.
Once investors have accumulate enough, they will push higher.

still got so many force selling.
Pity those contra players.